Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bosutinib and Allogeneic HSCT in CML
NCT02638467Phase 2Completed
- Sponsor
- University of Milano-Bicocca
- Start
- Nov 2015
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bosutinib in chronic myeloid leukemia (CML), sponsored by University of Milano-Bicocca. Started Nov 2015; status: completed.
02
Drugs
bosutinib
03
Conditions
chronic myeloid leukemia (CML)
Beyond the preview
Go deeper on NCT02638467.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02638467.